| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/18/1994 | CA2103318A1 Simultaneous determination of hba1 and haemoglobin variants with a glycation analogous to hba1 |
| 05/17/1994 | US5312751 Hybridoma producing a monoclonal antibody specific for an antigen of the stratum corneum of human epidermis |
| 05/17/1994 | US5312738 Vancomycins |
| 05/17/1994 | US5312736 DNA-sequence encoding the analog; expression vector containing the sequence; transformed or transfected microorganism or cell line comprising the vector; culture preparation of analog; drug including analog |
| 05/17/1994 | US5312733 Developmental marker gene of CD4-CD8 thymocytes |
| 05/17/1994 | US5312732 Hormone receptor compositions and methods |
| 05/14/1994 | CA2102673A1 Expression vectors for bovine trypsin and trypsinogen and host cells transformed therewith |
| 05/13/1994 | CA2102848A1 Altered affinity polypeptides of metal chelate binding antibodies |
| 05/11/1994 | WO1994010569A1 METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE β-AMYLOID PEPTIDE |
| 05/11/1994 | WO1994010339A1 Evolutive vaccination |
| 05/11/1994 | WO1994010338A1 Nuclear hormone receptor-interacting polypeptides and related molecules and methods |
| 05/11/1994 | WO1994010333A1 Crf binding protein |
| 05/11/1994 | WO1994010332A1 HUMANIZED ANTIBODIES TO Fc RECEPTORS FOR IMMUNOGLOBULIN G ON HUMAN MONONUCLEAR PHAGOCYTES |
| 05/11/1994 | WO1994010331A1 Angiogenesis inhibitory antibodies |
| 05/11/1994 | WO1994010329A1 Rna packaging system |
| 05/11/1994 | WO1994010317A2 Conjugate vaccine against group b streptococcus |
| 05/11/1994 | WO1994010314A1 Allergenic proteins and peptides from johnson grass pollen |
| 05/11/1994 | WO1994010313A2 Interferon tau compositions and methods of use |
| 05/11/1994 | WO1994010311A1 The pct-65 serotonin receptor |
| 05/11/1994 | WO1994010310A1 THE St-B17 SEROTONIN RECEPTOR |
| 05/11/1994 | WO1994010309A1 Novel p-selectin ligand protein |
| 05/11/1994 | WO1994010308A1 Methods of preparing soluble, oligomeric proteins |
| 05/11/1994 | WO1994010307A1 Transcription factor dp-1 |
| 05/11/1994 | WO1994010304A1 Marmoset zona pellucida protein zp3 |
| 05/11/1994 | WO1994010303A1 Multidrug resistance gene |
| 05/11/1994 | WO1994010300A1 Interaction trap system for isolating novel proteins |
| 05/11/1994 | WO1994010207A2 Truncated insulin-like growth factor binding proteins having mitogenic activity |
| 05/11/1994 | WO1994010203A2 Op-3-induced morphogenesis |
| 05/11/1994 | WO1994010202A1 Vascular endothelial cell growth factor antagonists |
| 05/11/1994 | WO1994010201A1 Peptides and vaccines derived from nematode tubulin |
| 05/11/1994 | WO1994010200A1 Somatotropin modifications |
| 05/11/1994 | WO1994010199A1 Expression and purification of cloned human alpha-fetoprotein |
| 05/11/1994 | WO1994010192A1 Process for manufacturing crystals of growth hormone and crystals thereby obtained |
| 05/11/1994 | WO1994010187A1 COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-$g(b) |
| 05/11/1994 | WO1994009828A1 Dna encoding a human serotonin receptor (5-ht4b) and uses thereof |
| 05/11/1994 | WO1994009821A1 Recombinant vaccine for porcine pleuropneumoniae |
| 05/11/1994 | WO1994009820A1 Prostate-specific membrane antigen |
| 05/11/1994 | WO1994009817A1 Novel antibody construct |
| 05/11/1994 | WO1994009803A1 Enhancement of xenograft tolerance and porcine cytokines therefor |
| 05/11/1994 | WO1994003620A3 Method of increasing expression of viral proteins |
| 05/11/1994 | EP0596725A2 Drug resistance-conferring protein, antibodies reactive therewith and utilities thereof |
| 05/11/1994 | EP0596479A2 Basophil-binding monoclonal antibody, method for separation of basophils, method for chemical mediator release from basophils, and method for testing release of basophil-derived chemical mediators |
| 05/11/1994 | EP0596459A2 Process for purifying recombinant proteins, and use of products thereof |
| 05/11/1994 | EP0596321A2 Process of unidimensional separation and identification of glycanes, the use of this process for the construction of databanks, the structure characterization of glycans and the relative determination of the Stokes radius of glycanes |
| 05/11/1994 | EP0596034A1 Purification of recombinant ciliary neurotrophic factor and c-terminal truncated ciliary neurotrophic factor and methods for treating peripheral nerve damage |
| 05/11/1994 | EP0596031A1 Neural calcium-activated neutral proteinase inhibitors |
| 05/11/1994 | EP0595997A1 PROTEIN V: A NOVEL IgG BINDING FACTOR |
| 05/11/1994 | EP0595855A1 Allergenic proteins and peptides from japanese cedar pollen |
| 05/11/1994 | EP0595838A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 05/11/1994 | EP0595822A1 Thyroidal receptor for n-acetylglucosamine |
| 05/11/1994 | EP0595798A1 Bispecific heteroantibodies with dual effector functions |
| 05/11/1994 | CN1086543A CDNA clones coding for polypepstides exhibiting human granulocyte macrophage and eosinophie cellular growth |
| 05/11/1994 | CA2448557A1 Multidrug resistance gene |
| 05/11/1994 | CA2148685A1 Truncated insulin-like growth factor binding proteins having mitogenic activity |
| 05/11/1994 | CA2148258A1 Transcription factor dp-1 |
| 05/11/1994 | CA2148244A1 Angiogenesis inhibitory antibodies |
| 05/11/1994 | CA2148119A1 Interferon tau compositions and methods of use |
| 05/11/1994 | CA2147756A1 Peptides and vaccines derived from nematode tubulin |
| 05/11/1994 | CA2147754A1 Compositions and methods for modifying the regulatory activity of tgf- .beta. |
| 05/11/1994 | CA2147598A1 Op-3-induced morphogenesis |
| 05/11/1994 | CA2147252A1 Rna packaging system |
| 05/11/1994 | CA2146926A1 Conjugate vaccine against group b streptococcus |
| 05/11/1994 | CA2146559A1 Methods of preparing soluble, oligomeric proteins |
| 05/11/1994 | CA2145546A1 Somatotropin modifications |
| 05/11/1994 | CA2126967A1 Novel antibody construct |
| 05/11/1994 | CA2120131A1 Expression and purification of cloned human alpha-fetoprotein |
| 05/10/1994 | US5310883 Stabilized versions of glu-3,5-basic FGF having eliminated disulfide scrambled forms; wound healing agents; promoters of angiogenesis, neutrotropism and chemotaxis |
| 05/10/1994 | US5310882 Somatotropins with alterations in the α-helix 3 region |
| 05/10/1994 | US5310876 Expression of HIV1 and HIV2 polypeptides and their use |
| 05/10/1994 | US5310873 Cyclohexapeptide compound |
| 05/10/1994 | US5310678 Genetic engineering, poultry |
| 05/10/1994 | US5310663 Affinity peptides |
| 05/10/1994 | US5310662 Receptors: their identification, characterization, preparation and use |
| 05/10/1994 | US5310660 Method and a hybrid promoter for controlling exogenous gene transcription |
| 05/10/1994 | US5310654 Method for determining virulence of Yersinia |
| 05/10/1994 | CA1329373C Process for recovering refractile bodies containing heterologous proteins from microbial hosts |
| 05/06/1994 | CA2102256A1 Drug resistance-conferring protein, antibodies reactive therewith and utilities thereof |
| 05/04/1994 | EP0595659A2 Extracellular matrix receptor ligands that modulate leukocyte function |
| 05/04/1994 | EP0595476A2 Dictyostelium dipeptidylaminopeptidase |
| 05/04/1994 | EP0595436A2 Porcine respiratory and reproductive disease virus, vaccines and viral DNA |
| 05/04/1994 | EP0595334A2 Mutant AOX2 promoter, vector carrying same, transformant, and production of heterologous protein |
| 05/04/1994 | EP0595241A2 Determination and inhibition of malic enzyme in tumor cells |
| 05/04/1994 | EP0594879A1 Cathepsin L-specific monoclonal antibodies, hybridomas for producing the same and a method of using the same |
| 05/04/1994 | EP0594847A1 Dna coding for human fk506-binding protein and expression thereof |
| 05/04/1994 | EP0594843A1 Antibody assay for amylin |
| 05/04/1994 | EP0594764A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 05/04/1994 | EP0594743A1 Continuous cell line and vaccine against avian coccidia |
| 05/04/1994 | EP0594732A1 Humanized antibody against cd18 |
| 05/04/1994 | EP0594710A1 Tyrosine kinase |
| 05/04/1994 | EP0594631A1 Bordetella bronchiseptica outer membrane antigen |
| 05/04/1994 | EP0594610A1 PROTEIN D - AN IgD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE |
| 05/04/1994 | EP0594576A1 Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products |
| 05/04/1994 | EP0516655B1 Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine |
| 05/04/1994 | EP0514413B1 Immunologically active peptides or polypeptides from the parvovirus b19 |
| 05/04/1994 | EP0413695B1 Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3. |
| 05/04/1994 | EP0229046B1 Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique |
| 05/04/1994 | CN1086265A Method for preparing natural interleukin-II |
| 05/04/1994 | CN1086264A Method for preparing antigenic protein capable of testing C-type hepatitis by using colibacillus |
| 05/04/1994 | CA2102251A1 Method for the one-dimensional fractionation and identification of glycans, and the use of this method for setting up data bases and for the determination of the structure of glycans and for the relative determination of the stokes radii glycans |
| 05/03/1994 | US5308750 Binders for hepatitis C virus and hybridomas and antigens |